Clinical Trial Update: AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on AR-42 in adults with advanced or relapsed multiple myeloma, chronic lymphocytic leukemia, and various lymphomas; the study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Hodgkin Lymphoma
• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• AR-42 (AR-42)

Snippet

Sponsor: Amir Mortazavi | Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma | Phase 1 | Status: COMPLETED